Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

Clinical trial NCT05413850 · RECRUITING

Trial details

NCT number: NCT05413850
Sponsor: Blue Earth Therapeutics Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-resistant Prostate Cancer mCRPC Urogenital Neoplasms Prostatic Neoplasms Prostatic Diseases

Start date: 2022-07-20
Primary completion: 2026-08-27
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.